report by BlackRock
Results for ""
Fixed Income Insights
Market Overview: Collateralized Loan Obligations
This piece is approved to use with clients.
Collateralized Loan Obligations (CLOs) are managed portfolios of bank loans that have been securitized into different instruments of varying credit risk and thus varying credit ratings.
Macroeconomic & Geopolitical
Japan Equities Outlook: What Can Tuna Auctions Tell Us About Future Market Trends?
This piece is approved to use with clients.
Junichi Inoue, Head of Japanese Equities, discusses why the Japanese stock market performed well last year despite its cyclicality and shares his outlook for a recovery in 2021.
Market Outlooks
Multi-Asset Outlook 2021: All Change
News of game-changing vaccines in late 2020 heralded a dramatic shift in expectations for markets and the economy in 2021. Paul O’Connor, Head of the UK-based Multi Asset Team, considers the rationale behind this optimism, and areas he believes can benefit.
Market Outlooks
2021 – In a Word: Recovery
This piece is approved to use with clients.
Andrew Mulliner, Portfolio Manager and Head of Global Aggregate Strategies, explains why 2021 will likely be a year of recovery, though he cautions that investors should keep one eye on inflation and inflation expectations.
Market Outlooks
AAM Viewpoints: A dive into 2020 Fixed Income Markets & what they tell us for 2021
This piece is approved to use with clients.
The unfolding of diverse and largely unseen set of events in 2020 make it difficult to select only a few that we feel represent the tenor of the fixed income markets and the broad economy within this commentary. Clearly, the migration back into risk assets beginning in Q2 (the 2nd quarter) continued through Q4 2020 buttressed by what we think can be four primary causes:
Market Outlooks
AAM Viewpoints: Let’s party like it’s 1999!
This piece is approved to use with clients.
As the calendar changed from 2020 to 2021, I can’t help but find an environment that is truly surreal. We have a raging global pandemic on our hands that is getting markedly worse on a day-by-day basis, we have vaccines that are sitting in warehouses being administered at one-tenth the rate that is necessary to accomplish the task at hand and we have millions without a job with difficult prospects of getting one in the near future.
Fixed Income Insights
Positioning for Higher Yields
This piece is approved to use with clients.
With higher government bond yields looking increasingly likely, Head of U.S. Fixed Income Greg Wilensky explains why investors should consider how much interest rate risk they have in their portfolios, and make sure it is appropriate for their needs.
Market Outlooks
AAM Viewpoints: Equity market side effects of the covid-19 vaccine
This piece is approved to use with clients.
The 337 days spanning the World Health Organization’s announcement of COVID-19 to the FDA approval of the first vaccine the world witnessed many social, economic, and scientific events few thought possible.